|
Groups
|
Co-infection viruses
|
NO. (%)
|
|---|
|
2 viruses (n = 14)
|
HMPV + IFV
|
4 (21.1)
|
| |
HMPV + RSV
|
3 (15.8)
|
| |
HMPV + HRV
|
2 (10.5)
|
| |
HMPV + WUPyV
|
2 (10.5)
|
| |
HMPV + ADV
|
1 (5.3)
|
| |
HMPV + HCoV
|
1 (5.3)
|
| |
HMPV + HBoV
|
1 (5.3)
|
|
3 viruses (n = 3)
|
HMPV + IFV + RSV
|
2 (10.5)
|
| |
HMPV + HRV + WUPyV
|
1 (5.3)
|
|
4 viruses (n = 1)
|
HMPV + HPIV + HCoV + ADV
|
1 (5.3)
|
|
5 viruses (n = 1)
|
HMPV + HPIV + RSV + ADV + WUPyV
|
1 (5.3)
|
- ADV adenovirus, HBoV human bocavirus, HCoV human coronavirus (HKU1/229E/OC43/NL63), HPIV human parainfluenza virus 1–4, HRV human rhinovirus, IFV influenza virus A–C, RSV respiratory syncytial virus, WUPyV WU polyomavirus
